A study to look at the effects of a hydrolat spray to palliate hot flushes in women being treated for breast cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN98658526

Enrollment

Registered

2007-09-28

Start date

2006-08-16

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Signs and Symptoms: Hot flushes Signs and Symptoms Hot flushes

Interventions

Randomized single blinded crossover study of two sprays

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Any woman suffering from hot flushes as a result of treatment for breast cancer.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
The number of women choosing a hydrolat spray in preference to a water spray to palliate hot flushes.	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026